Rock Health and the Stanford Center for Digital Health release their findings from the 2019 Consumer Adoption Survey. In 2019, overall consumer adoption of digital health leveled off near the 2018 high water mark. The five-year picture represented in our annual survey is one of a steady transition to a progressively more digital consumer healthcare experience.
When Halle Tecco set out to build Rock Health nearly ten years ago, she saw a need to support entrepreneurs using technology to make healthcare massively better. Today, we’re thrilled to announce our investment in her latest venture, Natalist, a company conceived to close the glaring gaps she encountered on her path to parenthood—and fueled by the belief that those who want to have children deserve a better way. We’re humbled to be a part of Natalist’s $5M seed round and to back an incredible team on a mission to radically improve the fertility experience.
Though funding slowed from the $2B per quarter pace in the first half of the year, digital health companies raised $1.3B in venture capital in Q3 2019 for a total of $5.5B in the year to date. This puts the sector on track for the second largest funding year ever. As in 2018, large deals continue to drive the overall trend. In this market update we discuss public market performance of the five 2019 digital health IPOs (early results are mixed) and two hot areas of investment: behavioral health and women’s health.
Medication errors cost the US healthcare system over $525B each year—roughly one in every six healthcare dollars spent. We’re excited to announce our investment in Arine, whose solution combines data science with clinical expertise to ensure patients are on the safest and most effective medication regimens.
We’re proud to announce our participation in InsightRX’s $10M Series A funding round to support their mission of individualizing drug treatment at the point of care.
As consumers increasingly take control of their own health and wellness, they drive market demand more directly. Devices, apps, and services are being created and tailored to meet their needs, enabling consumers to actively engage in health and wellness decision-making. To dig a little deeper beneath the surface of how industry players are adapting to this shift, we caught up with experts on the inside at GSK Consumer Healthcare, a Rock Health partner.
‘Tis the season of startup pitches, inspirational conversations, and even dance offs. You know what we’re talking about—the eighth annual Rock Health Summit is just over a month away. Here are seven agenda highlights we’re most excited for at this year’s Summit.
We’re proud to announce our newest investment in Vivante Health, the first all-in-one digital solution for digestive health and complex inflammatory conditions. Welcome, Vivante!
$4.2B was invested in digital health through the first half of 2019. The sector continues to experience healthy growth—we still don’t see the telltale signs of an investment bubble. Here we take stock of the capital invested in digital health startups since 2011—$29.4B of which is waiting on liquidity. We examine two avenues to return this capital: public offerings and acquisition by large non-healthcare companies.
Since 2012, Podimetrics has worked tirelessly on a remote patient monitoring (RPM) solution to tackle the devastating problem of diabetic foot ulcers. With clinically validated sensor technology and care coordination, Podimetrics is now launching its product to additional commercial payers and at-risk providers. We’re thrilled to announce our participation in Podimetrics’ $13.4M Series B.
Digital therapeutic and pharmaceutical companies are partnering to build, validate, and expand access to new, software-based solutions that improve patient outcomes. This is new territory with few precedents, and the strategies for building successful alliances remain uncertain. Drawing from numerous interviews with digital therapeutic, pharma, and health plan leaders, this research outlines how to overcome execution risks and build successful pharma-digital therapeutic alliances.
Coming off a record-smashing year for digital health funding in 2018, we see funding leveling off in the first quarter of 2019. Meanwhile, after a two-and-a-half-year drought, the digital health IPO market is heating up. Here’s the data and our take on how 2019 is shaking out so far for digital health.
Results from our fourth national consumer survey (2018 data) on digital health adoption and sentiments. Adoption continues to rise while consumers leverage digital health tools to address concrete health needs.
In a banner year for digital health funding, AI/ML companies raced to the top in dollars raised, investors showed excitement about on-demand healthcare services, and more women CEOs closed rounds than ever before—though they still represent a small sliver of the pie.
Since 2015, Blue Shield of California has partnered with Rock Health to gain exposure to digital health and elevate its position as an innovative healthcare company. Through its partnership with Rock Health, Blue Shield of California has showcased thought leadership, collaborated on research, and gained unparalleled insight into the frontlines of healthcare innovation.
Women are critical stakeholders in healthcare, serving as workers, caregivers, and consumers—yet they do not have an equal voice in the ranks of leadership. Our goal with this annual report is to contribute to a meaningful and actionable dialogue around women in leadership, with the hopes of providing a foundation for our industry to finally turn this dialogue into action.
After seven years, we’ve seen $23B invested into thousands of digital health companies. But we wanted to know: what has been the real-world impact of digital health? We were moved to learn just how many lives had been significantly changed by a new wave of technology. We aim to shift the digital health dialogue from one focused on the degree of investment and future expectations to one about digital health’s effect on patients and healthcare outcomes. In that spirit, this ongoing project brings you stories of people living far outside Silicon Valley and the companies shifting the healthcare status quo who have made an impact on their lives.
AI in healthcare feels inevitable: Optimists predict that artificial intelligence and machine learning (AI/ML) will diagnose disease better and earlier, treat illness more precisely, and engage patients more efficiently than today’s healthcare system does. On top of this, AI/ML is expected to streamline business operations and restore sanity (and humanity) to the clinician experience. To separate hype from reality, read our 50-page white paper, Demystifying AI and Machine Learning in Healthcare.